GTEx Muscle 20-29 vs 50-59 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Muscle 20-29 vs 50-59 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Muscle 20-29 vs 50-59 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Muscle 20-29 vs 50-59 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Muscle 20-29 vs 50-59 Up.

Results found

Linked to

 

Label

Description

 

Gene

double homeobox A pseudogene 8

Gene

p53 upregulated regulator of p53 levels

Gene

MIR34A host gene

Gene

long intergenic non-protein coding RNA 632

Gene

family with sequence similarity 225 member A

Gene

FEZF1 antisense RNA 1

Gene

long non coding transcriptional activator of miR34a

Gene

KLRK1 antisense RNA 1

Gene

S-phase cancer associated transcript 8

Gene

cytoskeleton associated protein 2-like pseudogene

  • Gene

    double homeobox A pseudogene 8


  • Gene

    p53 upregulated regulator of p53 levels



  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    family with sequence similarity 225 member A


  • Gene

    FEZF1 antisense RNA 1


  • Gene

    long non coding transcriptional activator of miR34a


  • Gene

    KLRK1 antisense RNA 1


  • Gene

    S-phase cancer associated transcript 8


  • Gene

    cytoskeleton associated protein 2-like pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.